Enter your login e-mail to the account
Search
Search parameters
Search results
- Klinická charakteristika, diagnostika, prevence a léčba rezistentní hypertenze
prof. MUDr. Jaroslav Šimon, DrSc.
(6/2009, Review articles ) - Svetový deň hypertenzie: pamätajme na soľ
doc. MUDr. Štefan Farský, FESC, predseda Slovenskej ligy proti hypertenzii
(6/2009, Press release ) - Topical corticosteroids in clinical practice in terms of efficacy and safety
doc. MUDr. Martin Hrubiško, PhD.
(1/2012, Drugs & drug classes ) - Pulmonary fibrosis – diffuse parenchymal lung diseases
MUDr. Bohumil Matula
(1/2010, Review articles ) - Tehotenstvo u pacientok so sclerosis multiplex
MUDr. Marianna Vitková, PhD.
(3/2018, Interdisciplinary consilium ) - Betamethasone in the treatment of painful musculoskeletal disorders – indications, efficacy and safety profile
Doc. MUDr. Peter Špalek, PhD., MUDr. Miroslav Satko
(1/2017, Interdisciplinary consilium ) - Multiple sclerosis – maternity and breastfeeding
MUDr. Olga Zapletalová
(6/2019, Interdisciplinary consilium )
- Pharmacotherapy of myastenia gravis
MUDr. Stanislav Voháňka, CSc., MBA
(2/2010, Main topic ) - Central nervous system vasculitis
MUDr. Aleš Tomek, Ph.D., FESO
(6/2015, Main topic ) - Challenges of ciclosporin and azathioprin dosage for myasthenia gravis
MUDr. Magda Horáková, MUDr. Stanislav Voháňka, CSc., MBA
(5/2017, Main topic ) - Immunosuppressive drugs in treating neurological diseases
MUDr. Jiří Piťha
(6/2011, Main topic ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Vaccination of patients with multiple sclerosis
MUDr. Daniel Dražan, MUDr. Tomáš Nečas
(5/2022, From the boundary of neurology ) - Ofatumumab in clinical practice
MUDr. Martin Elišák, Ph.D.
(1/2024, Review articles ) - Multiple sclerosis – maternity and breastfeeding
MUDr. Olga Zapletalová
(1/2019, Review articles ) - The risk of developing malignant tumors in the modern treatment of multiple sclerosis: a review of the literature
MUDr. Dagmar Brančíková, Ph.D.
(2/2019, From the boundary of neurology ) - Immunosuppressive treatment of multiple sclerosis and risk (of reactivation) of viral hepatitides
MUDr. Václav Hejda, MUDr. Aleš Tvaroh, Ph.D.
(4/2020, From the boundary of neurology ) - Secondary progressive multiple sclerosis: therapeutic nihilism or active approach?
MUDr. Jiří Piťha
(6/2019, Review articles ) - Léčba relaps-remitentní roztroušené sklerózy mozkomíšní
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová
(4/2008, Main topic )
- Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis
MUDr. Tomáš Tichý, doc. MUDr. Michal Hladík, Ph.D., MUDr. Tomáš Pískovský, MUDr. Helena Strmeňová, MUDr. Tomáš Zaoral, PhD.
(5/2011, Case reports ) - Glucocorticoid-induced osteoporosis in children – prevention and treatment
prof. MUDr. Ľudmila Podracká, CSc., MUDr. Kristína Kubejová
(3/2013, Review articles )
- Treatment options for patients with chronic immune thrombocytopenia
MUDr. Enikő Radi
(S3/2022, Case reports ) - New research and therapeutic targets in molecular genetics of tumors − our research potential
RNDr. Alena Gábelová, CSc., Mgr. Miroslav Chovanec, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Božena Smolková, PhD., Mgr. Viera Kajabová, PhD., RNDr. Ivana Fridrichová, CSc.
(1/2015, Main topic )
- Intravenous immunoglobulin in therapy of pemphigus vulgaris
prof. MUDr. Danka Švecová, PhD.
(4/2015, Review articles ) - Cutaneous leukocytoclastic vasculitis
MUDr. Hana Juhásová, doc. MUDr. Janette Baloghová, PhD.
(4/2023, Review articles )
- ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Risks and side effects of treatment of psoriasis in selected groups of patients
PharmDr. Marcel Jusko, PhD.
(3/2016, Current pharmacotherapy ) - COVID-19 and the lung: from interstitial pneumonia to pulmonary fibrosis
MUDr. Štefan Laššán, PhD., MPH, MUDr. Monika Laššánová, PhD.
(4/2023, Current pharmacotherapy )
- The using of mesenchymal stem cells in treatment of Type I. diabetes
prof. MUDr. Jozef Radoňak, CSc., doc. MUDr. Jana Kaťuchová, PhD., MUDr. Tomáš Hildebrand
(3/2012, Review articles )